September 2016 FDA Recall Cytotec by Pfizer Inc.
D-0424-2017 - Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months

This Class III drug recall was voluntarily initiated by Pfizer Inc. on September 9, 2016 for the product Cytotec. The FDA reported the reason for recall as failed impurities/degradations specifications; out of specification results for two known degradation products and total impurities at 18 months. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0424-2017

Reason for Recall
Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months
Initiated
09-09-2016
Reported
01-18-2017
Quantity
1,706 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Cytotec (misoprostol) Tablets, 200 mcg, 100 Tablets blister pack (10X10), For in-institution use only, Rx only, Distributed by G.D. Searle, Division of Pfizer, Inc., NY, NY --- NDC 0025-1461-34

Batch or Lot Expiration Information

Lot# 1)
Lot# B08493 - Expiration Date 12/2016; 2)
Lot# B13230 - Expiration Date 08/2018